Journal
NATURE REVIEWS CLINICAL ONCOLOGY
Volume 15, Issue 3, Pages 129-131Publisher
NATURE PORTFOLIO
DOI: 10.1038/nrclinonc.2017.174
Keywords
-
Categories
Funding
- CANCER-ID, an Innovative Medicines Initiative Joint Undertaking [115749]
- European Union's Seventh Framework Program
- EFPIA
- European Research Council [269081 DISSECT]
- Fashion Footwear Charitable Foundation of New York/QVC Presents Shoes on Sale
Ask authors/readers for more resources
We posit that disseminating tumour cells detected in the bone marrow or in the circulation are either cancer stem cells with full metastatic potential, tumour-bulk cells, or dormant cancer cells. This model has both therapeutic and diagnostic implications, raising concern over inadequate treatment as well as the possibility of overtreatment resulting from overdiagnosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
